Quinoclamine inhibits Shiga toxin production in enterohemorrhagic Escherichia coli

No abstract is available for this paper.

• Publication year

  2023

• Venue

  bioRxiv

• Publication date

  2023-09-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/2023.09.26.559460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Relevance of tracking the diversity of Escherichia coli pathotypes to reinforce food safety.

  2022cited by this paper
• Niclosamide—A promising treatment for COVID‐19

  2021cited by this paper
• Targeting the bacterial SOS response for new antimicrobial agents: drug targets, molecular mechanisms and inhibitors.

  2021cited by this paper
• Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

  2021cited by this paper
• Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs

  2020cited by this paper
• The role of the bacterial protease Prc in the uropathogenesis of extraintestinal pathogenic Escherichia coli

  2020cited by this paper
• Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

  2020cited by this paper
• The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli

  2019cited by this paper
• The 2011 German Enterohemorrhagic Escherichia Coli O104:H4 Outbreak-The Danger Is Still Out There.

  2018cited by this paper
• Niclosamide, a Drug with Many (Re)purposes

  2018cited by this paper
• Antibiotic-Induced Genetic Variation: How It Arises and How It Can Be Prevented.

  2018cited by this paper
• Niclosamide: Beyond an antihelminthic drug

  2017cited by this paper
• Current pathogenic Escherichia coli foodborne outbreak cases and therapy development

  2017cited by this paper
• Environmental Factors and Zoonotic Pathogen Ecology in Urban Exploiter Species

  2017cited by this paper
• Microbiological effects of sublethal levels of antibiotics

  2014cited by this paper
• SOS, the formidable strategy of bacteria against aggressions.

  2014cited by this paper
• The ecological habitat and transmission of Escherichia coli O157:H7.

  2013cited by this paper
• Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies

  2012cited by this paper
• Shiga Toxin Subtypes Display Dramatic Differences in Potency

  2011cited by this paper
• Prevalence and characterization of Shiga toxin-producing Escherichia coli O157 and O26 in beef farms.

  2011cited by this paper
• Bacteriophages carrying Shiga toxin genes: genomic variations, detection and potential treatment of pathogenic bacteria.

  2011cited by this paper
• Shiga toxins — from cell biology to biomedical applications

  2010cited by this paper
• Phylogenetic Ubiquity and Shuffling of the Bacterial RecBCD and AddAB Recombination Complexes

  2009cited by this paper
• Acute bloody diarrhea: a medical emergency for patients of all ages.

  2009cited by this paper
• Shiga Toxin 2 Is Specifically Released from Bacterial Cells by Two Different Mechanisms

  2009cited by this paper
• The Defective Prophage Pool of Escherichia coli O157: Prophage–Prophage Interactions Potentiate Horizontal Transfer of Virulence Determinants

  2009cited by this paper
• Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks

  2008cited by this paper
• Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations

  2007cited by this paper
• Phage regulatory circuits and virulence gene expression.

  2005cited by this paper
• The Operator and Early Promoter Region of the Shiga Toxin Type 2-Encoding Bacteriophage 933W and Control of Toxin Expression

  2004cited by this paper
• Escherichia coli RecX Inhibits RecA Recombinase and Coprotease Activities in Vitro and in Vivo *

  2003cited by this paper
• Synthesis and MEK1 inhibitory activities of imido-substituted 2-chloro-1,4-naphthoquinones.

  2003cited by this paper
• Genome sequence of enterohaemorrhagic Escherichia coli O157:H7

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

  2000cited by this paper
• Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans

  1999cited by this paper
• Synthesis and antiplatelet, antiinflammatory, and antiallergic activities of 2-substituted 3-chloro-1,4-naphthoquinone derivatives.

  1997cited by this paper
• Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.

  1995cited by this paper
• Furin-induced Cleavage and Activation of Shiga Toxin (*)

  1995cited by this paper
• Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice

  1993cited by this paper
• Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

  1988cited by this paper
• Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus

  1987cited by this paper
• Studies on Effects of Certain Quinones: II. Photosynthetic Incorporation of CO(2) by Chlorella.

  1972cited by this paper
• Studies on Effect of Certain Quinones: I. Electron Transport, Photophosphorylation, and CO(2) Fixation in Isolated Chloroplasts.

  1972cited by this paper

• No citing papers are available for this paper.